Melanotan 2 (MT2 injection) Melanotan ii peptide injection wholesale UK
CAS 121062-08-6
Purity (by HPLC): 99%
Appearance: White Powder
CAS Number: 121062-08-6
Molecular Formula: C50H69N15O9
Molecular weight: 1024.2
Storage Condition; away from light, cold storage (2-8 degree)
Usage: prevention sunlight-induce skin cancer; Sexual Dysfunction & Fat Decomposition

What is Melanotan 2 ?
Melanotan 2  Tanning Injections (otherwise known as MT2) was first synthesized at the University of Arizona.  Researches  there knew that onc of the best defenses against skin cancer was melanin activated in the skin, a tan.  They hypothesized  that an effective way to reduce skin cancer rates in people would be to induce the body's natural pigmentary system to  produce a protective tan prior to UV exposure.  The body's naturally occuring hormone MSH causes melanogenesis, a  process by which the skin's pigment cells (melanocytes) produce the skin's pigment (melanin).  They tested to see if  administering this endogenous hormone to the body directly could be an effective method to cause sunless tanning.  What  they found was that while it appeared to work, natural MSH had too short a half life in the body to be practical as a  therapeutic drug.  So they decided to find a more potent and stable alternative, one that would be more practical.

After synthesizing and screening hundreds of molecules, the researchers headed by Victor J. Hruby and Mac E. Hadley, found  a peptide, [Nle4, D-Phe7] MSH, that was approimately 1,000 times more potent than the natural MSH.  They dubbed this  new peptide molecule, "Melanotan" (later Melanotan-1, now know as afamelanotide).  They subsequently developed  another analog, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2), which they called "Melanotan" Tanning Injections.  The  scientists hoped to use these peptides to combat melanoma by stimulating the body's natural pigmentary mechanism to  create a tan without first needing exposure to harmful levels of UV radiation.  This in turn, they hypothesized, could reduce  the potential for skin damage that can eventually lead to skin cancer.

A pilot phase I clinical trial conducted on three males by the College of Medacine, Pharmacology Department, University of  Arizona in Tuscon, Arizona pulished in 1996 reported that, "Melanotan" Tanning Injections has tanning activity in humans  given only 5 low doses every other day by subcutaneous injection."  The side effects reported were mild nausea and a  "stretching and yawning complex" that correlated with spontaneous penile erections.

The Department of Pharmacology, University of Arizona College of Medacin published in 1998 that involved 10 men who  suffered from psychogenic erectile dysfunction.  Their trial concluded that, "Melanotan" Tanning Injections is a potent  initiator of erections in men with pyschogenic erectile dydfunction and has manageable side effects at a dose of  0.025mg/kg.

A clinical study published in 2000 of 20 men with psychogenic and organic erectile dysfunction conducted at the Section of  Urology of The University of Arizona College of Medacin concluded, "that Melanotan II Tanning Injections is a potent  initiator of penile erection in men with ecrectile dysfunction.

How much dosage Melanotan II should be used?

In most studies favorable results have been shown with dosages around 500mcg or 5mcg/kg per day or every other day with  the dosage split 1/2 30 minutes prior to tanning and the other 1/2 immediately after tanning for the first week.
After the first week a maintenance dose of 500mcg or 5mcg/kg was used 1-3 times a week with the dosage split 1/2 30  minutes prior to tanning and the other 1/2 immediately after tanning.